Group for people who have participated in any of the trials with otelixizumab. Such as DEFEND, DEFEND-2, TTEDD and all the other ones at are coming out.
Please share your changes in insulin, BG, A1C, your experiences on the trial.
Website: http://www.tolerrx.com/index.php?page=trx4
Members: 11
Latest Activity: Jul 6, 2012
Started by lindanu. Last reply by t.clayton Apr 27, 2011. 3 Replies 0 Likes
LONDON—GlaxoSmithKline PLC and its U.S. partner Tolerx Inc. Friday said their experimental drug otelixizumab failed to pass a late-stage clinical trial for Type 1 diabetes.The two companies in a…Continue
Started by lindanu. Last reply by lindanu Mar 10, 2011. 10 Replies 0 Likes
So we went in four the first MMTT since dosing. He had an MMTT twice prior to dosing. the first time his BG was 122 in the morning and 244 two hours after the boost. That was three weeks after…Continue
Started by SuFu, Ph.D.. Last reply by samsmom Feb 28, 2011. 10 Replies 0 Likes
Julie,I hope you don't mind but I'll start a discussion form so that we can all benefit from the replies. If you son received the drug, that is not an uncommon response. There are two other people at…Continue
Started by lindanu. Last reply by lindanu Feb 21, 2011. 2 Replies 0 Likes
I posted this on 'parent's of kids' but decided to move it here.Wow Julie, you son had an immediate response!! Yesterday my son had very little insulin. He woke up at 101 and had 65 carbs and 2…Continue
Comment
Comment by SuFu, Ph.D. on July 6, 2012 at 8:40am Nothing so far on my end either. I just emailed the coordinator so we'll see if anything comes from that.
No, they have not said anything about following up with him. Gosh i wish he could get another dose, I swear it made a difference. Last year at this time he was taking about 6 units of humulog per day.
Haven't heard anything yet. Do they plan to follow up with him at all?
Just got a call from our endo. Study is unblinded. Reece did get the drug. Anyone else hear?
This drug, otelixizumab, has been used in trials in Europe also. Our trial here is ending because the research shows it didn't perform as expected. The hope was that it would extend the "honeymoon" phase where the Type 1 patient is still producing some of their own insulin. There are similar drugs currently in trials. If you google otelixizumab, you'll see the related news. Another drug tried this way is teplizumab. I see a lot of research focusing on the honeymoon phase, or stopping the body's autoimmune attack. The thing about these trials is that you have to sign up right after diagnosis.
Comment by NICKOLE on February 10, 2012 at 1:35pm Hi, iam in England.....My friend lives in Romania. In my country is not a lot of information about this drug.
Nickole, we're talking about a drug tested in a clinical trial here in the U.S. Where are you? You can check for drug trials online -- or try contacting a diabetes organization where you are for information.
Comment by NICKOLE on February 7, 2012 at 4:28am we got the letter which says it officially ends in March 2012. It doesn't mention telling us, but i'm sure they will. I think my endo considers very little insulin a honeymoon.
Just got back from our trial check-up. Dr said they have results showing that there is no difference between the drug group and the control group. He said they have determined that there are no adverse effects after the one-year mark, so that's why there's no reason to follow patients after visit 12. I said, "Did Samantha have a long honeymoon on her own?" He said, "She didn't have a honeymoon." He considers it no honeymoon since she has required insulin - it doesn't matter how much. He said he's not sure if they will tell us who got the drug: there is some letter that is already written & ready to go but it will take months to go through the proper channels. So -- we have one more visit in Feb.
Manny Hernandez(Co-Founder, Editor, has LADA)
|
Bradford (has type 1) |
Lorraine (mother of type 1) |
Marie B (has type 1) |
|
|
|
|
|
|
This site complies with the HONcode standard for trustworthy health information: verify here.
© 2013 A community of people touched by diabetes, run by the Diabetes Hands Foundation.

You need to be a member of Otelixizumab (TRX-4) Trial Participants to add comments!